Status: Recruiting
Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants
This study aims to evaluate the feasibility and effects of nicotinamide riboside (NR) supplementation in lactating mothers of infants expected to be hospitalized in the neonatal intensive care unit (NICU) for at least four weeks.
Participants needed: 40
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of California, DavisUpdated: Sep 14, 2026Locations: 1
Eligibility criteria
Not listed